Spatial transcriptomics reveals substantial heterogeneity in triple-negative breast cancer with potential clinical implications
Xiaoxiao Wang(Université Libre de Bruxelles), Christos Sotiriou(Université Libre de Bruxelles)
Cited by 67
Related Papers
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
|New England Journal of Medicine|2016|2k
Breast cancer classification and prognosis based on gene expression profiles from a population-based study
|Proceedings of the National Academy of Sciences|2003|2k
Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial
|Annals of Oncology|2014|1.3k
The 2019 World Health Organization classification of tumours of the breast
|Histopathology|2020|1.1k